Adipic Acid

Adipic Acid

SCHEMBL851390

C=CC=C.O=C(O)CCCCC(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC18A2SLC6A2SLC6A3

The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.69
TSHR P16473 4/20 0.65
NFKB1 P19838 2/20 0.65
PMP22 Q01453 1/20 0.65
ABCC4 O15439 1/20 0.64
MAPT P10636 1/20 0.64
SLC22A6 Q4U2R8 2/20 0.59
GPR84 Q9NQS5 4/20 0.52
FFAR1 O14842 2/20 0.52
FFAR4 Q5NUL3 2/20 0.52
AKR1B1 P15121 1/20 0.52
CYP2D6 P10635 1/20 0.52
FOLH1 Q04609 1/20 0.52
PPARG P37231 5/20 0.50
PPARD Q03181 5/20 0.50
PPARA Q07869 5/20 0.50
HDAC11 Q96DB2 4/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butadiene SCHEMBL2257807 0.97 TSHR (0.71) LMNATSHRNFKB1PMP22ABCC4
Sebacic Acid SCHEMBL4053732 0.97 TSHR (0.71) LMNATSHRNFKB1PMP22ABCC4
Azelaic Acid SCHEMBL4051535 0.97 TSHR (0.71) LMNATSHRNFKB1PMP22ABCC4
Octanedioate SCHEMBL4052467 0.97 TSHR (0.71) LMNATSHRNFKB1PMP22ABCC4
Glutarate SCHEMBL4061457 0.94 SLC22A6 (0.69) LMNATSHRNFKB1PMP22ABCC4
Adipic Acid SCHEMBL27801856 0.88 LMNA (0.69) LMNATSHRNFKB1PMP22ABCC4
Hexanoate SCHEMBL27601168 0.87 AKR1B1 (0.76) LMNATSHRMAPTSLC22A6GPR84
Succinic Acid SCHEMBL4061508 0.87 LMNA (0.64) LMNATSHRNFKB1PMP22ABCC4
Stearic Acid SCHEMBL10835517 0.85 GPR84 (0.77) LMNATSHRMAPTSLC22A6GPR84
Adipic Acid SCHEMBL3293975 0.85 LMNA (0.65) LMNATSHRNFKB1PMP22ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013818-B1 A BIODEGRADABLE BIOCOMPOSITE AND A PROCESS FOR ITS PREPARATION FONDAZIONE ST ITALIANO TECNOLOGIA (IT) 2025-01-01 EP claimed
US-20220314515-A1 A BIODEGRADABLE BIOCOMPOSITE AND A PROCESS FOR ITS PREPARATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2022-10-06 US claimed
EP-4013818-A1 A BIODEGRADABLE BIOCOMPOSITE AND A PROCESS FOR ITS PREPARATION Fondazione Istituto Italiano di Tecnologia (IT) 2022-06-22 EP claimed
WO-2021028816-A1 A BIODEGRADABLE BIOCOMPOSITE AND A PROCESS FOR ITS PREPARATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2021-02-18 WO claimed
EP-2764063-B1 PHOTO-CURABLE INK COMPOSITION HP SCITEX LTD (IL) 2018-01-24 EP claimed
CN-102280662-B A kind of battery with nonaqueous electrolyte DONGGUAN AMPEREX TECHNOLOGY CO., LTD. (CN) 2016-03-30 CN claimed
EP-2432830-B1 BIOPLASTICS WACKER CHEMIE AG (DE) 2013-07-10 EP claimed
US-20120135169-A1 Bioplastics WACKER CHEMIE AG (DE) 2012-05-31 US claimed
EP-2432830-A1 BIOPLASTICS Wacker Chemie AG (DE) 2012-03-28 EP claimed
CN-102280662-A Non-water electrolyte battery 2011-12-14 CN claimed
WO-2010133560-A1 BIOPLASTICS WACKER CHEMIE AG (DE) 2010-11-25 WO claimed
CN-117624275-B Liver-targeting sugar ligand molecule modified by double-antenna GalNAc and drug carrying system thereof JIAYING UNIVERSITY (CN) 2026-05-26 CN disclosed
EP-4013818-B1 A BIODEGRADABLE BIOCOMPOSITE AND A PROCESS FOR ITS PREPARATION FONDAZIONE ST ITALIANO TECNOLOGIA (IT) 2025-01-01 EP disclosed
US-20240301114-A1 POLYCARBONATE DIOL AND PRODUCING METHOD THEREOF, AND POLYURETHANE AND ACTIVE ENERGY RAY-CURABLE POLYMER COMPOSITION BOTH FORMED USING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-12 US disclosed
WO-2024112195-A1 POLYMER COMPOSITE COMPRISING MICRONIZED FELDSPAR Rosiro Intellectual Property B.V. (NL) 2024-05-30 WO disclosed
US-7236302-B2 Diffraction optical element CANON KABUSHIKI KAISHA (JP) 2007-06-26 US disclosed
US-20070115533-A1 MICROCAPSULE, ELECTROPHORETIC DISPLAY SHEET, ELECTROPHORETIC DISPLAY DEVICE, AND ELECTRONIC APPARATUS SEIKO EPSON CORPORATION (JP) 2007-05-24 US disclosed
US-20060292481-A1 Toner and method of manufacturing toner KONICA MINOLTA BUSINES TECHNOLOGIES, INC. 2006-12-28 US disclosed
US-20050243423-A1 Diffraction optical element CANON KABUSHIKI KAISHA (JP) 2005-11-03 US disclosed
EP-1591806-A1 Diffractive optical element CANON KABUSHIKI KAISHA (JP) 2005-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240301114-A1 POLYCARBONATE DIOL AND PRODUCING METHOD THEREOF, AND POLYURETHANE AND ACTIVE ENERGY RAY-CURABLE POLYMER COMPOSITION BOTH FORMED USING SAME DIMT1, CAD, PUF60 LMNA 1615/4885TSHR 3647/4885NFKB1 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.